Author guidelines

Scope

Gastroenterology Report is an international open access (OA) journal covering all areas related to gastrointestinal sciences, including studies of the alimentary tract, liver, biliary, pancreas, enteral nutrition and related fields. The journal aims to publish high quality research articles on both basic and clinical gastroenterology, authoritative reviews that bring together new advances in the field, as well as commentaries and highlight pieces that provide expert analysis of topical issues.

How we publish

Gastroenterology Report is a peer-reviewed fully open access journal that publishes one issue per year online. All papers published in the Journal are made freely available online under open access publishing agreements, with applicable charges. Please refer to the open access section below.

After copyediting and review of the final proof, papers are published in the currently open volume.

Submitting

Publishing in Gastroenterology Report means that you are publishing with Oxford University Press (OUP), a not-for-profit publisher and a department of the University of Oxford. Learn more about how publishing with OUP reinvests in the scholarly community on the OUP For Authors page.

After preparing your manuscript according to the guidance in the Preparing your manuscript section, you can submit your work through the Journal’s online submission site. If you have not used our submission site before, you will need to create an account. Additional help and instructions are available on the submission site as you go through the process. Please contact us with any questions about submitting your manuscript.

Article types

Articles come under one of seven article types. Each manuscript is composed of main document, figure files (if applicable), and supplementary material (if applicable). Depending on the article type of your paper, please include the following components in the main documents. All article types undergo the Journal's standard peer review process unless otherwise stated.

Original articles 

A complete, comprehensive report of clinical, basic, or translational study. Structured abstract (no more than 270 words); keywords (4–6 words); main text (no more than 7,500 words); authors’ contributions; acknowledgements; funding; conflict of interest; references; figure legends; tables.

Meta analysis or Systematic review

Structured abstract (no more than 270 words, including background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number); keywords (4–6 words); main text (no more than 7,500 words); authors’ contributions; acknowledgements; funding; conflict of interest; references; figure legends; tables.

Reviews

A comprehensive analysis and/or synthesis of any specific topics. Unstructured abstract (no more than 250 words); keywords (4–6 words); main text (no more than 10,000 words); authors’ contributions; acknowledgements; funding; conflict of interest; references; figure legends; tables.

Brief reports

Including, but being not limited to, a description of unique or rare cases, novel treatments such as surgery and medicine, special findings in pathologic, imaging, or endoscopic examinations, techniques or mechanistic insights, and new animal models of human diseases. No abstract or keywords; main text (no more than 1,000 words); acknowledgements; funding; conflict of interest; references (no more than 10); the title and legend of one figure or one table (if applicable).

Consensus

Unstructured abstract (no more than 270 words); keywords (4–6 words); main text; acknowledgements; conflict of interest information; references; figure legends; tables.

Editorials

Invited only. No abstract or keywords; main text (no more than 1,000 words); acknowledgements; conflict of interest; references (no more than 10); the title and legend of one figure or one table (if applicable). Editorials are reviewed by Editors and are not sent for external peer review.

Commentary

No abstract or keywords; main text (no more than 1,000 words); acknowledgements; conflict of interest information; references (no more than 10); figure legend (no more than one figure); table (no more than one table).

Letter to the Editor

Comment on GR articles online published in the last six months. No abstract or keywords; main text (no more than 1,000 words); conflict of interest; references (no more than 10); figures and tables are not permitted.

Peer review process

The Journal operates single-anonymized peer review, meaning that the identity of the authors is known to the editors and to the reviewers, but that the reviewers’ identities are known only to the editors and are hidden from the authors.

During peer review, reviewers communicate directly with the editors but not the authors or other reviewers.

Once a submitted manuscript passes initial assessment by the Journal’s Editor-in-Chief, it will then be passed to a handling editor, who will oversee peer review and recommend a final decision. The Editor-in-Chief makes the final decision on the submitted manuscript. 

Editors and reviewers must not handle manuscripts if they have a conflict of interest with an author or the content. Editors make every effort to avoid potential conflicts of interest in the assignment of other editors and peer reviewers. For more information, please see the section on Disclosure of potential conflicts of interest. During the peer review phase, your manuscript is typically sent to two reviewers. 

You may suggest potential reviewers at submission. However, there is no guarantee the suggested reviewers will be selected by the Journal. Recommended reviewers should be experts in their field and able to provide an objective assessment of your manuscript without financial or interpersonal conflicts of interest with any authors. We encourage you to consider reviewers from a diverse range of backgrounds, including those from under-represented communities. 

At the time of submission, you may request that specific individuals are not used as reviewers of your manuscript. Please indicate any opposed reviewer(s) when asked during the submission. You may also be asked to provide a brief explanation of why you oppose them. Please note there is no guarantee these individuals will be excluded by the Journal.

Statistical methods should be rigorous, and reporting of statistical findings should be accurate and complete. Editors may request an expert statistical review of any submission containing statistical analysis. 

If your manuscript is accepted for publication, no information about the review process or editorial decision process is published, unless one of the authors has a role on the journal. See the Disclosure of potential conflicts of interest section for more information in that case.

For full details about the peer review process, see Fair editing and peer review. 

Manuscript transfers

In some cases, the editorial team of the Journal may offer you the option of transferring your manuscript to Journal of the Canadian Association of Gastroenterology (JCAG) or Research Connections. If you accept this offer, the manuscript files and any reviewer reports from consenting reviewers will be sent to Journal of the Canadian Association of Gastroenterology (JCAG) or Research Connections. The editorial team of the receiving journal may choose to seek additional peer review. A decision will be made on the manuscript based on the feedback from all reviewers and the judgment of the receiving journal's editorial team.

Screening for misconduct

Manuscripts may be screened using iThenticate to help detect publication misconduct including plagiarism and redundant publication.

Manuscripts may also be screened, including with services provided by third parties, to help detect integrity issues such as inappropriate image alteration and papermill activity.

Appeals and complaints

Authors may appeal an editorial decision. To do so, please contact the editorial office at [email protected], providing as much specific detail as possible about why the original decision should be reconsidered. Every appeal will receive a response within a reasonable timeframe. Please do not resubmit your manuscript in the interim.

To register a complaint regarding non-editorial decisions, the Journal’s policies and procedures, editors, or staff, please contact [email protected]. Complaints will be taken seriously and will be carried forward following COPE guidelines and processes.

Publication and research ethics

Authorship

Authorship is limited to those who have made a significant contribution to the design and execution of the work described. Any contributors whose participation does not meet the criteria for authorship should be acknowledged but not listed as an author. The Journal will contact all listed authors at the point of submission to confirm their role. For a detailed definition of authorship, please see the International Committee of Medical Journal Editors (ICMJE) definitions of authors and contributors.

The Journal does not allow ghost authorship, where an unnamed author prepares the article with no credit, or guest/gift authorship, where an author who made little or no contribution is listed as an author. The Journal follows Committee on Publication Ethics (COPE) guidance on ghost, guest, or gift authorship. For more information, please see our Publication Ethics page.

Natural language processing tools driven by artificial intelligence (AI) do not qualify as authors, and the Journal will screen for them in author lists. The use of AI (for example, to help generate content or images, write code, process data, or for translation) should be disclosed both in cover letters to editors and in the Methods or Acknowledgements section of manuscripts. Please see the COPE position statement on Authorship and AI for more details.

Authorship changes

After manuscript submission, no authorship changes (including the authorship list, author order, and who is designated as the corresponding author) should be made unless there is a substantive reason to do so. The editor and all co-authors must agree on the change(s), and neither the Journal nor the publisher mediates authorship disputes. If individuals cannot agree on the authorship of a submitted manuscript, contact the editorial office at [email protected]. The dispute must be resolved among the individuals and their institution(s) before the manuscript can be accepted for publication. If an authorship dispute or change arises after a paper is accepted, contact our Author Support team. COPE provides guidance for authors on resolving authorship disputes.

After submission, changing the corresponding author in order to access Read and Publish or other forms of institutional funding is not permissible. For more information on Read and Publish funding, see the Open access charges section.

ORCID

Authors are encouraged to provide their ORCID iDs (Open Researcher and Contributor iDs) at submission and take advantage of the benefits of participating in ORCID. If you do not already have an ORCID iD, you can register for free via the ORCID website. 

As ORCID identifiers are collected, they are displayed in both the online and PDF versions of the publication, in compliance with recommended practice issued by ORCID.

ORCID functionality online allows users to link to the ORCID website to view an author’s profile and list of publications. ORCID iDs are displayed on web pages and are sent downstream to third parties in data feeds, where supported.

If you have registered with ORCID, you can associate your ORCID iD with your submission system account by going to your account details, entering your ORCID iD, and validating your details. Learn more about ORCID and how to link it to your account.

Group authorship

Groups (also known as corporate, organization, or collective names) who meet the authorship criteria should be included in the main author list. At least one individual must be designated on behalf of the group as the primary point of contact during the peer review and production processes, as well as for correspondence following publication. You may list this individual separately in the main author list if desired. A complete list of the individual members of the group must be included in the manuscript under Acknowledgements.

Disclosure of AI use

OUP provides guidance on the responsible use of generative artificial intelligence (Gen AI) and AI-assisted technologies in developing content for publication in our journals. Authors must follow the central Policy on AI Use & Disclosure for OUP Journals Authors.

Disclosure of potential conflicts of interest

Authors

The Journal requires all authors to disclose any potential conflict of interest at the point of submission. It is the responsibility of the corresponding author to ensure that conflicts of interest of all authors are declared to the Journal.

A conflict of interest exists when the position, activities, or relationships of an individual, whether direct or indirect, financial or non-financial, could influence or be seen to influence the opinions or activities of the individual. For more information, refer to our definition of conflict of interest.

The Journal follows the COPE guidance for any suspected undisclosed conflict of interest before and after publication.

Reviewers

Individuals who have a conflict of interest relating to a submitted manuscript should recuse themselves and will not be assigned to oversee, handle, or peer review the manuscript.

If during peer review an editor, reviewer, or author becomes aware of a conflict of interest that was not previously known or disclosed they must inform the Editor-in-Chief or Editorial Office immediately.

Editors and editorial board members

At initial submission, the corresponding author must declare if the Editor-in-Chief, an editor, or an editorial board member of the Journal is an author of or contributor to the manuscript. Another editor without a conflict of interest will oversee the peer review and decision-making process. If accepted, a statement will be published in the paper describing how the manuscript was handled. The statement will read “[Author name] holds the position of [role] for Gastroenterology Report and has not peer reviewed or made any editorial decisions for this paper."

Previously published material

You should only submit your manuscript(s) to the Journal if:

  • It is original work by you and your co-author(s).
  • It is not under consideration, in peer review, or accepted for publication in any other publication  whilst under consideration in this journal.
  • It has not been published in any other publication.
  • It contains nothing abusive, defamatory, derogatory, obscene, fraudulent, or illegal.

The submitting author must disclose in their cover letter and provide copies of all related or similar preprints, dissertations, manuscripts, published papers, and reports by the same authors (i.e., those containing substantially similar content or using the same, similar, or a subset of data) that have been previously published or posted electronically or are under consideration elsewhere at the time of manuscript submission. You must also provide a concise explanation of how the submitted manuscript differs from these related manuscripts and papers. All related previously published papers should be cited as references and described in the submitted manuscript.

The Journal does not discourage you from presenting your findings at conferences or scientific meetings but recommends that you refrain from distributing complete copies of your manuscripts, which might later be published elsewhere without your knowledge.

For previously published materials including tables and figures, please see the Reusing copyrighted material section.

Preprints

As an author, you retain the right to make an Author’s Original Version (preprint) available through various channels and this does not prevent submission to the Journal. If accepted, you are required to update the status of any preprint, including adding your published paper’s DOI. For full details on allowed channels and updating your preprint, please see our Author self-archiving policy.

Reusing copyrighted material

As an author, you must obtain permission for any material used within your manuscript for which you are not the rightsholder, including quotations, tables, figures, images, data, or software. In seeking permissions for published materials, first contact the publisher rather than the author. For unpublished materials, start by contacting the creator. Copies of each grant of permission should be provided to the editorial office of the Journal. The permissions agreement must include the following:

  • Non-exclusive rights to reproduce the material in your paper in Gastroenterology Report
  • Rights for use in print and electronic format at a minimum, and preferably for use in any form or medium
  • Lifetime rights to use the material
  • Worldwide English-language rights

If you have chosen to publish under an open access licence but have not obtained open access re-use permissions for third-party material contained within the manuscript, this must be stated clearly by supplying a credit line alongside the material with the following information:

  • [Title of content]
  • [Author], [Original publication], [year of original publication], by permission of [rights holder]
  • This image/content is not covered by the terms of the Creative Commons licence of this publication. For permission to reuse, please contact the rights holder.

Refer to a summary of rights and permissions information for authors or see our detailed Copyright and Permissions Guidelines. 

Misconduct

Authors should observe high standards with respect to research integrity and publication ethics as set out by the Committee on Publication Ethics (COPE). Falsification or fabrication of data including inappropriate image manipulation, plagiarism, including duplicate publication of the author's own work without proper citation, and misappropriation of work are all unacceptable practices. Allegations of ethical misconduct, both directly and through social media, are treated seriously and will be investigated in accordance with the relevant COPE guidance and the Journal may publish an Expression of Concern to inform readers about an ongoing matter in a published article.

If misconduct has been established beyond reasonable doubt, this may result in one or more of the following outcomes, among others:

  • If a submitted manuscript is still under consideration, it may be rejected and returned to the author.
  • If a paper has already been published online, depending on the nature and severity of the infraction, either a correction notice will be published and linked to the paper, or retraction of the paper will occur, following the COPE Retraction Guidelines.
  • The relevant party’s institution(s) and/or other journals may be informed.

Manuscripts submitted to the Journal may be screened with plagiarism-detection software. Any manuscript may be screened, especially if there is reason to suppose that part or all of the manuscript has been previously published.

COPE defines plagiarism as:

“when somebody presents the work of others (data, words or theories) as if they were their own and without proper acknowledgment.”

COPE defines redundant/overlapping publication as: 

“when a published work (or substantial sections from a published work) is/are published more than once (in the same or another language) without adequate acknowledgment of the source/cross-referencing/justification,
or
when the same (or substantially overlapping) data is presented in more than one publication without adequate cross-referencing/justification, particularly when this is done in such a way that reviewers/readers are unlikely to realise that most or all the findings have been published before.”

COPE defines citation manipulation as: 

“behaviours intended to inflate citation counts for personal gain, such as: excessive self-citation of an authors’ own work, excessive citation to the journal publishing the citing article, and excessive citation between journals in a coordinated manner.”

Data fabrication is defined as intentionally creating fake data or misrepresenting research results. An example includes making up data sets.

Data falsification is defined as manipulating research data with the purpose of intentionally giving a false representation. This can apply to images, research materials, equipment, or processes. Examples include cropping of gels/images to change context and omission of selected data.

If notified of a potential breach of research conduct or publication ethics, the Journal editor and editorial office staff may inform the publisher and/or the author’s institutional affiliation(s). Authors should be prepared to provide additional information on request. 

Ethical research

The Journal takes research integrity seriously, and all research published in the Journal must have been conducted in a fair and ethical manner. Wherever appropriate, the Journal requires that all research be done according to international and local guidelines.

Human participants

When reporting on human participants, you should indicate whether the procedures followed were in accordance with the ethical standards of the Helsinki Declaration, which were developed by the World Medical Association. For non-interventional studies, where ethical approval is not required or where a study has been granted an exemption by an ethics committee, this should be stated within the manuscript with a full explanation. Otherwise, manuscripts must include a statement in the Methods section that the research was performed after approval by a local ethics committee, institutional review board and/or local licensing committee, or that such approval was not required. The name of the authorizing body and any reference/permit numbers (where available) should also be stated there. Please be prepared to provide further information to the editorial office upon request.

Human participants must give written informed consent, or if they are minors or incapacitated, such consent must be obtained from their parents or guardians. Consent forms should cover not only study participation but also the publication of the data collected and deposition in databases and/or biobanks. Also, any patient or provider information should be anonymized to the extent possible; names and ID numbers should not be used in the text and must be removed from any images (X-rays, photographs, etc.). Please note blanking out an individual’s eyes in a photograph is not an effective way to conceal their identity. In studies where verbal, rather than written, informed consent was obtained, this must be explained and stated within the manuscript. If informed consent is not required or where a study has been granted an exemption, this must be included in the Methods section along with the name of the authorizing body. The Journal does not routinely collect consent forms, but authors should be prepared to provide written consent forms signed by the participants or other appropriate documentation to the editorial office upon request. For further guidance and examples, please refer to COPE’s guidance on consent.

Clinical trials

Clinical trials should be registered before enrollment of the first participant in accordance with the criteria outlined by the International Committee of Medical Journal Editors (ICMJE). When reporting primary or secondary analyses from a clinical trial, follow these criteria:

  • Provide the trial registration number at the end of the Abstract.
  • When the trial acronym is first used in the manuscript, provide the registration number and a link to the trial registration, which should be cited as a reference.
  • If your data have been deposited in a public repository and/or are being used in a secondary analysis, please state at the end of the Abstract the unique, persistent data set identifier, and repository name and number.
  • When submitting the manuscript, you must disclose any protocol alterations and all posting of results of the submitted work or closely related work in registries.

Clinical trials should comply with the Consolidated Standards of Reporting Trials Statement (CONSORT). Authors reporting on randomized clinical trials (RCT) should consult the CONSORT checklist when preparing their manuscripts. All RCT data will be evaluated in accordance with the rules and checklist of the CONSORT statement.

  • Other types of studies should follow guidelines where available. These include Standards for the Reporting of Diagnostic accuracy studies (STARD), Strengthening the reporting of observational studies in epidemiology (STROBE), Transparent Reporting of Systematic Reviews and Meta-Analyses (PRISMA) and Meta-analyses of observational studies (MOOSE).
  • For further information on good reporting of health research studies please go to the EQUATOR network.

Where available, registration numbers should be provided not only for the trial you are reporting but also for any other trial mentioned in the manuscript. When the trial acronym is first used in the manuscript, provide the registration number and a link to the trial registration, which should be cited as a reference. 

Animals

Studies involving animals require approval from the relevant institutional ethics committee or institutional animal use and care committee, and the research must be conducted in accordance with applicable national and international guidelines. All such manuscripts must include a statement in the Methods section providing details of the name of the committee(s) that approved the study, as well as the permit or animal license numbers where available. Where a study has been granted an exemption, this must be stated in the Methods section along with the name of the authorizing body. Please be prepared to provide further information to the editorial office upon request.

Manuscripts describing research involving laboratory-based animals must include details on housing, husbandry, and steps taken to reduce suffering. In studies where experimental animals were euthanized, details must be provided on humane endpoints. Details on the planned behavioral observations or physiological measurements used to determine the humane endpoint must be described. You are advised to consult the NC3Rs guide on Humane Endpoints and the American Veterinary Medical Association (AVMA) Guidelines for the Humane Slaughter of Animals.

Accessibility

Written, visual, and audio content in your submission should be accessible to all. Please see the C4DISC guidelines for making text, images, charts, tables, and audio and video accessible.

Availability of data and materials

Where ethically feasible, the Journal strongly encourages authors to make all data and software code on which the conclusions of the paper rely available to readers. Whenever possible, data should be presented in the main manuscript or additional supporting files or deposited in a public repository. Visit our Research data page for information on general repositories for all data types, and resources for selecting repositories by subject area. When data and software underlying the research article are available in an online source, authors should include a full citation in their reference list. For details of the minimum information to be included in data and software citations see our guidance on citing research data and software.

Choosing where to archive your data

Authors are highly encouraged to select a repository that issues DOIs as this helps to facilitate persistent linking to the dataset from the research article. You may refer to online resources such as FAIRsharing.org and re3data.org for lists of data repositories, including information on certification status and services offered.

We suggest you consider these options when choosing your repository:

Digital preservation

Content published in the Journal will automatically be deposited into digital preservation services, including CLOCKSS, the Global LOCKSS Network, and Portico. This ensures the long-term preservation of your work. Through LOCKSS, participating institutions can sustain access to content if the Journal were to otherwise be unavailable, even for a short period of time. Should the Journal ever cease to publish, or content otherwise become permanently unavailable, long-term access to the archives of CLOCKSS and Portico would be triggered. Until such a trigger event were to occur, this content is not available to the public through CLOCKSS and Portico.

Self-archiving

Self-archiving refers to posting a copy of your work on a publicly accessible website or repository. Under certain circumstances, you may self-archive versions of your work on your own webpages, on institutional webpages, and in other repositories. For information about the Journal's policy, and to learn which version(s) of your paper are acceptable for self-archiving, please see our Author self-archiving policy.

Publishing agreement

Authors, please read each section on the publishing agreement and charges carefully.

If you have any questions relating to your publishing agreement or charges, please contact OUP Support.

After your manuscript is accepted, you will be asked to sign a licence to publish through our licencing and payment portal, SciPris. The Journal is fully open access, meaning all papers in the Journal are published under an open access licence. The corresponding author will need to arrange payment of an open access charge to publish in the Journal. This charge allows all published papers to be freely available to all readers immediately upon online publication. Editorial decisions occur prior to this step and are not influenced by payment or ability to pay. Papers can be published under the following:

  • Creative Commons Attribution licence (CC BY)
  • Creative Commons Attribution Non-Commercial licence (CC BY-NC)

Please see our guidance on Licences, copyright, and re-use rights for more information regarding these publishing agreement options.

Complying with funder mandates

Please note that some funders require open access publication as a condition of funding. If you are unsure whether you are required to publish open access, please clarify any such requirements with your funder or institution before selecting your licence.

Further information on funder mandates and direct links to a range of funder policies.

Charges

Open access charges

As the Journal is fully open access, you must pay the open access charge or request to use an institutional agreement to pay the article processing charge (APC) through our licencing and payment portal, SciPris. Find more details of open access licences and charges. 

Please use this tool to see the applicable APC for your paper, and to explore whether your institution has a Read and Publish agreement with us which may pay the open access charge.

The fee may be paid in other currencies at a rate determined when you sign the publishing agreement for your manuscript.

Charges are quoted based on the information provided. The Low and Middle Income Countries discount is applied prior to any other discount.

Please note that these prices are subject to change. All stated charges are exclusive of any applicable value added tax, goods and services tax and any similar sales or excise taxes (Sales Taxes). Any Sales Taxes will be added to the invoiced charge at the prevailing rate, as applicable.

The fee may be paid in other currencies at a rate determined when you sign the license for your manuscript.

Read and publish

We have Read and Publish agreements with institutions and consortia which provide funding for open access publishing. This means corresponding authors from participating institutions can publish open access, and the institution may pay the charge.

Find out if your institution has a Read and Publish agreement with us and visit the agreement page to find out if you meet the specific eligibility guidance.

To be eligible for one of our Read and Publish agreements, the corresponding author must provide their qualifying institution as their primary affiliation when they submit their manuscript. After submission, changing the corresponding author in order to access Read and Publish funding is not permissible.

Please note that these prices are subject to change. All stated charges are exclusive of any applicable value added tax, goods and services tax and any similar sales or excise taxes (Sales Taxes). Any Sales Taxes will be added to the invoiced charge at the prevailing rate, as applicable.

OUP has a growing number of open access agreements with institutions and consortia, which provide funding for open access publishing (also known as Read and Publish agreements). This means corresponding authors from participating institutions can publish open access, and the institution may pay the charge. Find out if your institution has an open access agreement.

To be eligible for one of OUP’s Read and Publish agreements, the corresponding author must provide their qualifying institution as their primary affiliation when they submit their manuscript. After submission, changing the corresponding author in order to access Read and Publish funding is not permissible.

As an open access journal, we rely on article processing charges for the journal's continued operation, and we ask authors to ensure they are able to pay these charges before submitting a paper. However, we acknowledge this is not always possible for all authors. Corresponding authors based in Low and Middle Income countries and regions may receive a waiver or discount of their article processing charge (APC). For further details, please see our open access waiver policy.

Waivers

We will consider waiver requests from authors based at institutions outside the Low and Middle Income countries initiative, but please note our ability to grant such discretionary waivers is limited. If you would like to request a discretionary waiver, we ask that you follow the discretionary waiver application process on our APC Waiver Policy Page. Please note that a waiver for open access charges should be requested before manuscript acceptance. If granted, a waiver does not guarantee manuscript acceptance. Waiver acceptance or rejection does not affect the peer review or editorial process, as waivers are managed by in-house staff, and editors and reviewers are not informed of waiver eligibility or receipt.

Colour charges

The Journal does not charge for colour.

Page charges

The Journal does not have page charges.

Changes to published papers

The Journal will only make changes to published papers if the publication record is seriously affected by the academic accuracy of the published information. Changes to a published paper will be accompanied by a formal correction notice linking to and from the original paper.

As needed, we follow the COPE guidelines on retractions.

For more information and details of how to request changes, including for authors who wish to update their name and/or pronouns, please see our policy on changes to published papers.

Promoting your work

As the author, you are the best advocate for your work, and we encourage you to be involved in promoting your publication. Sharing your ideas and news about your publication with your colleagues and friends could take as little as 15 minutes and will make a real difference in raising the profile of your research.

You can promote your work by:

  • Sharing your paper with colleagues and friends. If your paper is published open access, it will always be freely available to all readers, and you can share it without any limitations. Otherwise, use the toll-free link that is emailed to you after publication. It provides permanent, free access to your paper, even if your paper is updated.
  • Signing up for an ORCID iD author identifier to distinguish yourself from any other researchers with the same name, create an online profile showcasing all your publications, and increase the visibility of your work.
  • Using social media to promote your work. To learn more about self-promotion on social media, see our social media guide for authors.

Find out how OUP promotes your content. 

Preparing your manuscript

General guidelines on preparing your manuscript for publication can be found on our Preparing and submitting your manuscript page. Specific instructions for Gastroenterology Report can be found below.

Pre-submission language editing

You may wish to use a language-editing service before submitting to ensure that editors and reviewers understand your manuscript. OUP partners with Enago, a leading provider of author services. Through the OUP-Enago partner page, prospective authors are entitled to a discount for language editing, abstract and layperson summary writing, rejected manuscript editing, and creation of graphical abstracts, illustrations, and videos.

Enago is an independent service provider, and will handle all aspects of this service, including payment. As an author, you are under no obligation to take up this offer. Language editing and other services from Enago are optional and do not guarantee that your manuscript will be accepted. Edited manuscripts will undergo the regular review process of the Journal. For more details and a list of additional resources, please see our page on language services.

Online Search Engine Optimization (SEO)

You can improve the online accessibility of your paper by submitting an optimized copy that is highly indexable across all search engines. A large number of readers find articles online by using search engines such as Google. Most searching is done using keywords or key phrases. Including key phrases that people are likely to use for searching should make your article more discoverable. By taking some simple steps to optimize your article for search engines it will help your work to be discovered and read. This may in turn lead to the work being cited in others' work and will further raise the visibility of your article. Future measures, which assess the value of journals and of individual articles based on the number of times they are downloaded, are currently being developed and tested by UK Serials Group (UKSG) and Cranfield University Library.

Title page

The title should be short, specific, and informative. A running title of no more than 50 characters, which may include abbreviations/acronyms, should also be offered. The first name, initial(s), and surname of each author should be followed by his or her department, institution, city, state or province (if possible), and country. The fax, telephone number, mail address (including street, city, state or province with postcode and country), and Email address of the corresponding author should also be provided. Co-corresponding authors are not recommended. If necessary, it is our editorial policy to list no more than three authors (from different affiliations) for correspondence and these authors cannot be from the same institute. Any changes of address may be given next to the Affiliations or Acknowledgements. A footnote stating “The authors wish it to be known that, in their opinion, the first x (no more than three) authors should be regarded as joint First Authors” or “xxx, xxx, and xxx contributed equally to this paper.” is permitted if requested. Any deletions or additions to the author list after acceptance of the paper must be submitted in writing, signed by all authors, to the editorial office.

It is important that authors ensure the following: (i) all names have the correct spelling and are in the correct order (first name, then family name); (ii) initials are correct. Occasionally, the distinction between surnames and forenames can be ambiguous, and this is to ensure that the authors’ full surnames and forenames are tagged correctly, for accurate indexing online.

Abstract

The second page of the manuscript should contain the Abstract, written in English. A structured Abstract is required for Original articles and Meta analysis or Systematic reviews, and must include the following separate sections: 

  • State the context and purpose of the study
  • Background
  • Methods, describe how the study was performed and statistical tests used
  • Results, list the main findings
  • Conclusions, state brief summary and potential implications

Please minimize the use of abbreviations in the Abstract; however, each abbreviation used should be defined at the first mention in the Abstract. For clinical trials, the clinical registry website and trial number should be stated at the end of the Abstract. The Abstract should be comprehensible to readers before they have read the paper, and reference citations must be avoided.

An unstructured Abstract is required for Reviews.

Abbreviations

Non-standard abbreviations should be defined at the first occurrence and introduced only where multiple use (usually more than three times) is made. Authors should not use abbreviations in headings.

Manuscript structure

Introduction

This section should position the study with regard to objective, rationale, and preceding work of other authors.

Materials and methods/Patients and methods

This section should be divided into headed subsections. To reduce a lengthy methods section, experimental details (buffer compositions, primer sequences, etc.) may be included in a separate supplementary file for online publication. However, each method must be briefly described and thoroughly referenced in the main article.

For investigations involving procedures with animals or animal tissues, the main Methods section should provide the generic name of the anaesthetic and analgesic agent(s) used, the dose, and the route and frequency of administration. Note also that neuromuscular blocking or paralytic agents should never be used without general anaesthesia. Methods used for monitoring of the adequacy of anaesthesia must be described. Methods used for euthanasia should likewise be explicitly described. For experiments involving isolated tissues or primary cell cultures, the procedures used for their isolation should be described, including methods of anaesthesia and/or euthanasia. Finally, it should be stated whether the investigation conforms to either the Guide for the Care and Use of Laboratory Animals published by the United States National Institutes of Health or the Directive 2010/63/EU of the European Parliament.

If human subjects or tissues are used, you should state whether the investigation conforms with the principles outlined in the Declaration of Helsinki.

In addition, for both animal and human research, you should declare whether approval was granted by a local or university ethics review board (approval reference number to be given, if available). All manuscripts will be sent to an ethics subeditor for approval, if applicable, before the peer-review process is initiated.

Results

If pertinent, the section may be divided into headed subsections. For presentation of data, figures are preferred to tables. Also, extensive numerical data should appear in legends to the figures rather than in the main body of text.

Discussion

This section should not contain paragraphs dealing with topics that are beyond the scope of the study. Four manuscript pages should in general be enough to compare and interpret the data with regard to previous work by yourself and others. The discussion should follow a general format that looks something like this: 1) recap of the key findings in the study (without comparing them to other studies); 2) description of how the findings in the study compare to other studies/sources; 3) discussion of the study limitations; and 4) discussion of the ideas the reader should take from the paper (the conclusions) and the future directions or future studies warranted.

Depending on the type of study, please confirm that your manuscript meets the following checklist:

Authors’ contributions

Each author’s contribution to the paper should be listed using complete sentence, in which the author initials are the subject. At the end of this section, add this sentence: “All authors read and approved the final manuscript.” For example, “Z.C.Y., Y.B.L., and M.H.D. conceived and designed the project. Y.B.W., B.X.Z., and Z.C.Y. collected the data. Z.Y.X., R.X.L., Y.S.Z., M.X.X., Y.L., H.L., and G.H.C. analyzed and interpreted the data. B.X.Z. and Z.C.Y. drafted the manuscript. All authors read and approved the final manuscript.”

Funding

Details of all funding sources for the work in question should be given in a separate section entitled "Funding". This should appear before the "Acknowledgements" section. The following rules should be followed:

  • The sentence should begin: "This work was supported by …"
  • The full official funding agency name should be given, i.e. "the National Cancer Institute at the National Institutes of Health" or simply "National Institutes of Health" not "NCI" (one of the 27 subinstitutions) or "NCI at NIH" (full RIN-approved list of UK funding agencies)
  • Grant numbers should be complete and accurate and provided in brackets as follows: "[grant number ABX CDXXXXXX]"
  • Multiple grant numbers should be separated by a comma as follows: "[grant numbers ABX CDXXXXXX, EFX GHXXXXXX]"
  • Agencies should be separated by a semi-colon (plus "and" before the last funding agency)
  • Where individuals need to be specified for certain sources of funding the following text should be added after the relevant agency or grant number "to [author initials]".
  • An example is given here: "This work was supported by the National Institutes of Health [P50 CA098252 and CA118790 to R.B.S.R.] and the Alcohol & Education Research Council [HFY GR667789]."      

Crossref Funding Data Registry

In order to meet your funding requirements authors are required to name their funding sources, or state if there are none, during the submission process. For further information on this process or to find out more about CHORUS, visit the CHORUS initiative.

Acknowledgements

Acknowledgements and details of non-financial support must be included at the end of the text before references and not in footnotes. Personal acknowledgements should precede those of institutions or agencies. Please note that acknowledgement of funding bodies and declarations regarding conflicts of interest should be given in separate Funding and Conflicts of interest sections, respectively.

Conflicts of interests

If any, please state; if not, please write this sentence: “The authors declare that there is no conflict of interests in this study.” Refer to the section on Disclosure of Conflicts of Interest for more guidance.

References

Full references should be provided in accordance with the style of Gastroenterology Report.

These should be numbered in order of appearance in the text (in square brackets) and must be listed numerically in the reference list. Journal titles and author initials should be properly abbreviated and punctuated. Please truncate page numbers, i.e. type 345–9. The citation of journals, books, multi-author books and articles published online should conform to the following examples:

  • [Journal article] Kennedy T, Jones R. Effect of obesity on esophageal transit. Am J Surg 1985; 149 :177–81.
  • [Book] Long HC, Blatt MA, Higgins MC et al. Medical Decision Making. Boston: Butterworth-Heinemann, 1997.
  • [Chapter in book] Manners T, Jones R, Riley M. Relationship of overweight to haitus hernia and reflux oesophagitis. In: Newman W (ed.). The Obesity Conundrum. Amsterdam: Elsevier Science, 1997, 352–74.
  • [Online journal article] Qiao D, Chen W, Stratagoules E et al. (10 March 2000) Bile acid-induced activation of activator protein-1 requires both extracellular signal-regulated kinase and protein kinase C signaling. J Biol Chem, 10.1074/jbc.M908890199.

Personal communications (J.Jones, personal communication) must be authorized in writing by those involved, and unpublished data should be cited in the text as (unpublished data). References to manuscripts submitted, but not yet accepted, should be cited in the text as (B.Jones and L.Smith, manuscript in preparation) and should not be included in the list of references. Citations of submitted manuscripts should include all authors involved.

Authors are encouraged to cite web URLs in parentheses at the appropriate mention in the text.

Authors are responsible for checking the accuracy of all footnotes and references.

Journal Copyediting Style

This journal follows our standard Oxford SciMed style. By following the mini style checklist you can ensure that your manuscript follows the major style points.

Figures And Illustrations

Please be aware that the requirements for online submission and for reproduction in the journal are different: (i) for online submission and peer review, please upload your figures either embedded in the word processing file or separately as low-resolution images (.jpg, .tif, .gif or .eps); (ii) for reproduction in the journal, you will be required after acceptance to supply high-resolution .tif files. Minimum resolutions are 300 d.p.i. for colour or tone images, and 600 d.p.i. for line drawings. We advise that you create your high-resolution images first as these can be easily converted into low-resolution images for online submission.

Figures will not be relettered by the publisher. The journal reserves the right to reduce the size of illustrative material. Any photomicrographs, electron micrographs or radiographs must be of high quality. Wherever possible, photographs should fit within the print area or within a column width.

The figure title and legends should be listed at the end of the main text, rather than being a part of the figure file.

Be sure to remove all names and other patient identifiers from photos and radiographic images.

Figure accessibility and alt text

When submitting your manuscript, we require you to provide alt text (alternative text) descriptions for all images, figures, illustrations, and photographs included in the main article.  

Please consider accessibility when designing each figure, so that all images can be easily understood by visually impaired readers. OUP provides detailed guidance on figure accessibility, including contrast, text accessibility and alt text. It is also best practice for the information or data represented in the image to be fully described by the caption and/or surrounding text.

Please include each alt text description in your main manuscript file, directly under the figure caption for the relevant figure, preceded by ‘Alt text:’.  

Detailed guidance on how to draft and submit alt text.   

Including alt text in your manuscript helps make your work more accessible to all readers. Good alt text ensures that individuals with visual impairments or those using screen readers can understand the content and context of your figures. The aim of alt text is to give concise and informative descriptions of your figures so all readers can understand and benefit from the visuals in your manuscript. Including alt text demonstrates a commitment to accessibility and enhances the overall impact and reach of your work.  

Alt text is only accessible via e-reader and will not appear as part of the typeset article.   

Tables

All tables should be on separate pages and accompanied by a title, and footnotes where necessary. The tables should be numbered consecutively using Arabic numerals. Units in which results are expressed should be given in parentheses at the top of each column and not repeated in each line of the table. Ditto signs are not used. Avoid overcrowding the tables and the excessive use of words. The format of tables should be in keeping with that normally used by the journal; in particular, vertical lines, coloured text and shading should not be used. Please be certain that the data given in tables are correct.

Supplementary Data

Supporting material that is not essential for inclusion in the full text of the manuscript, but would nevertheless benefit the readers, can be made available by the publisher as online-only content, linked to the online manuscript. The material should not be essential to understanding the conclusions of the paper, but should contain data that are additional or complementary and directly relevant to the article content. Such information might include more detailed methods, extended data sets/data analysis, or additional figures.

It is standard practice for appendices to be made available online-only as supplementary data. All text and figures must be provided in suitable electronic formats. All material to be considered as supplementary data must be submitted at the same time as the main manuscript for peer review. It cannot be altered or replaced after the paper has been accepted for publication, and will not be edited. Please indicate clearly all material intended as supplementary data upon submission and name the files e.g. "Supplementary Figure S1", "Supplementary Data", etc. Also ensure that the supplementary data is referred to in the main manuscript where necessary, for example as "(see Supplementary data)" or "(see Supplementary Figure S1)".

Drug Disclaimer

The mention of trade names, commercial products or organizations, and the inclusion of advertisements in Gastroenterology Report does not imply endorsement by the Society, the editors, the editorial board, Oxford University Press or the organization to which the authors are affiliated. The editors and publishers have taken all reasonable precautions to verify drug names and doses, the results of experimental work and clinical findings published in Gastroenterology Report. The ultimate responsibility for the use and dosage of drugs mentioned in Gastroenterology Report and in the interpretation of published material lies with the medical practitioner, and the editors and publishers cannot accept liability for damages arising from any errors or omissions in Gastroenterology Report. Please inform the editors of any errors.

Disclaimer

Statements of fact and opinion in the articles in Gastroenterology Report are those of the respective authors and contributors and not of the Journal, Digestive Science Publishing Co. Limited, or Oxford University Press, unless otherwise expressly indicated. Neither Oxford University Press, Digestive Science Publishing Co. Limited, nor the Journal make any representation, express or implied, in respect of the accuracy of the material in the Journal and cannot accept any legal responsibility or liability for any errors or omissions that may be made. Readers should make their own evaluation as to the appropriateness or otherwise of the information included.

Contact us

For questions regarding submission and review, including appeals, you can reach the editorial office by email at [email protected].

After your paper has been sent to production, you can contact [email protected] for questions regarding publishing agreements and charges, the production process, or publication. Please see Changes to published papers if you need to request a substantive change to your published paper.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close

Gift article access

As a benefit of your subscription, you can share temporary access to restricted articles.

Each link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.

Please sign in to your personal account to gift article access.

Gift article access

Please create a link below to share with others. This will provide temporary access to this restricted article.

The link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.

Gift articles remaining: --

Gift article access

The link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.

Gift articles remaining: --

Gift article access

As a benefit of your subscription, you can share temporary access to restricted articles.

Each link will stop working after 30 days or 10 uses.

You have reached the limit of 10 links within a 30 day period